menu
    • menu

    Company profile for SPR Therapeutics

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    SPR Therapeutics, Inc. is a privately-held medical device company committed to improving the lives of millions of pain sufferers with its peripheral nerve stimulation (PNS) platform technology poised to be the standard of care and ultimately, the treatment of choice for pain management. Led by a world-class team of scientists, physicians, and business professionals with a track record of commercializing innovative neurostimula...
    SPR Therapeutics, Inc. is a privately-held medical device company committed to improving the lives of millions of pain sufferers with its peripheral nerve stimulation (PNS) platform technology poised to be the standard of care and ultimately, the treatment of choice for pain management. Led by a world-class team of scientists, physicians, and business professionals with a track record of commercializing innovative neurostimulation products, SPR’s PNS therapy for acute and chronic pain management provides a non-narcotic, reversible, safe, effective and more affordable alternative to addictive opioid medications and invasive surgeries.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SPR TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    22901 Millcreek Boulevard Suite 110 Cleveland, Ohio 44122
    Telephone
    Telephone
    (844) 378-9108
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.sprtherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/spr-therapeutics-llc
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    SPRINT PNS System Now Covered Nationally By Aetna
    SPRINT PNS System Now Covered Nationally By Aetna

    13 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/13/3255603/0/en/SPRINT-PNS-System-Now-Covered-Nationally-by-Aetna.html

    GLOBENEWSWIRE
    13 Mar 2026
    Share Share
    SPR to Feature Five Abstracts on SPRINT® PNS at ASPN 2025
    SPR to Feature Five Abstracts on SPRINT® PNS at ASPN 2025

    17 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/17/3117347/0/en/SPR-to-Feature-Five-Abstracts-on-SPRINT-PNS-at-ASPN-2025.html

    GLOBENEWSWIRE
    17 Jul 2025
    Share Share
    ASPN releases guidelines for 60-Day PNS therapy with SPR® SPRINT
    ASPN releases guidelines for 60-Day PNS therapy with SPR® SPRINT

    07 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/07/3111111/0/en/The-American-Society-of-Pain-and-Neuroscience-ASPN-Publishes-Consensus-Guidelines-for-the-Use-of-60-Day-Peripheral-Nerve-Stimulation-PNS-Therapy-Highlighting-Strong-Clinical-Applic.html

    GLOBENEWSWIRE
    07 Jul 2025
    Share Share
    SPR Wins 4th Northeast Ohio Top Workplaces Award
    SPR Wins 4th Northeast Ohio Top Workplaces Award

    30 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/30/3107445/0/en/SPR-Receives-Fourth-Consecutive-Northeast-Ohio-Top-Workplaces-Award.html

    GLOBENEWSWIRE
    30 Jun 2025
    Share Share
    SPR Publishes Chronic Shoulder Pain Outcomes Up to Five Years
    SPR Publishes Chronic Shoulder Pain Outcomes Up to Five Years

    28 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/28/3089860/0/en/SPR-Announces-Publication-of-Sustained-Chronic-Shoulder-Pain-Outcomes-Up-to-Five-Years-Post-Treatment.html

    GLOBENEWSWIRE
    28 May 2025
    Share Share
    Sprint PNS Meets Primary Endpoint in Monarch Study
    Sprint PNS Meets Primary Endpoint in Monarch Study

    21 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/21/3085887/0/en/SPRINT-PNS-Meets-Primary-Endpoint-of-Reduction-in-Head-Pain-in-First-Publication-of-Multicenter-Prospective-MONARCH-Study.html

    GLOBENEWSWIRE
    21 May 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search